BioAmber Overview

  • Year Founded
  • 2008

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 60

Employees

  • Latest Deal Type
  • M&A

  • Investors
  • 1

BioAmber General Information

Description

Provider of renewable succinic acid and related chemical intermediate products in Canada. The company's proprietary technology platform combines industrial biotechnology and chemical catalysis to convert bio-based feedstocks into renewable chemicals such as polyurethanes, resins and coatings, de-icing and coolant solutions, fine chemicals, lubricants, carpets, engineering plastics and artificial leather products, enabling clients to avail industrial chemical solutions.

Contact Information

Website
www.bio-amber.com
Formerly Known As
DNP Green Technology
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 1250 René-Lévesque Boulevard West
  • Suite 4310
  • Montreal, Quebec H3B 4W8
  • Canada
Primary Industry
Industrial Chemicals
Corporate Office
  • 1250 René-Lévesque Boulevard West
  • Suite 4310
  • Montreal, Quebec H3B 4W8
  • Canada

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

BioAmber Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
14. Merger/Acquisition 01-Jan-2024 Completed Generating Revenue
13. Bankruptcy: Liquidation 31-Jul-2018 Completed Bankruptcy: Liquidation
12. Secondary Transaction - Open Market 28-Feb-2018 Completed Generating Revenue
11. PIPE 12-Feb-2018 Cancelled Generating Revenue
10. Secondary Transaction - Open Market 15-Mar-2017 Completed Generating Revenue
9. 2PO 24-Jan-2017 Completed Generating Revenue
8. 2PO 15-Jan-2016 Completed Generating Revenue
7. 2PO 01-May-2015 Completed Generating Revenue
6. Debt Refinancing 19-Dec-2014 $25M $211M Completed Generating Revenue
5. Debt - General 18-Jul-2013 $25M $186M Completed Generating Revenue
To view BioAmber’s complete valuation and funding history, request access »

BioAmber Patents

  • 91

    Total Documents Applications and Grants

  • Total Patents Families

  • 35

    Granted

  • 2

    Pending

  • Expiring in next 12 mo

BioAmber Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2018205037-A1 Tools and methods for genome editing issatchenkia orientalis and other industrially useful yeast Inactive 12-May-2017
WO-2018018151-A1 Methylenemalonic acid and intermediates, processes for their preparation and engineered microorganisms Inactive 28-Jul-2016
WO-2017048767-A1 Curable coating compositions using succinic acid Inactive 14-Sep-2015
JP-2018526969-A Biobased production of functionalized alpha-substituted acrylates and c4 dicarboxylates Pending 04-Jun-2015
WO-2016196962-A1 Biobased production of functionalized alpha-substituted acrylates and c4-dicarboxylates Inactive 04-Jun-2015 C12N15/81
To view BioAmber’s complete patent history, request access »

BioAmber Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

BioAmber Former Investors (13)

Investor Name Investor Type Holding Investor Since Participating Rounds
AquaRIMCO Venture Capital Minority
Avrio Capital Venture Capital Minority
Bioindustrial Innovation Canada Not-For-Profit Venture Capital
Export Development Canada Corporation Majority
Lanxess Deutschland Corporation Minority
You’re viewing 5 of 13 investors. Get the full list »

BioAmber Investments & Acquisitions (5)

BioAmber’s most recent deal was a Secondary Transaction - Private with Bioamber Sarnia. The deal was made on 01-Aug-2017.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Bioamber Sarnia 01-Aug-2017 Secondary Transaction - Private Industrial Chemicals
Succinic Acid Production (BioAmber and CJ CheilJedang) 01-Jul-2017 Joint Venture Specialty Chemicals
Comet Bio 25-Feb-2015 Later Stage VC Food Products
Sinoven Biopolymers 04-Feb-2010 Merger/Acquisition Other Commercial Products
Bioamber Sarnia 01-Jan-2010 Joint Venture Industrial Chemicals
To view BioAmber’s complete investments and acquisitions history, request access »

Ready to get started?

Request a free trial

BioAmber FAQs

  • When was BioAmber founded?

    BioAmber was founded in 2008.

  • Where is BioAmber headquartered?

    BioAmber is headquartered in Montreal, Canada.

  • What is the size of BioAmber?

    BioAmber has 60 total employees.

  • What industry is BioAmber in?

    BioAmber’s primary industry is Industrial Chemicals.

  • Is BioAmber a private or public company?

    BioAmber is a Private company.

  • What is BioAmber’s current revenue?

    The current revenue for BioAmber is .

  • How much funding has BioAmber raised over time?

    BioAmber has raised $257M.

  • Who are BioAmber’s investors?

    AquaRIMCO, Avrio Capital, Bioindustrial Innovation Canada, Export Development Canada, and Lanxess Deutschland are 5 of 13 investors who have invested in BioAmber.

  • When was BioAmber acquired?

    BioAmber was acquired on 01-Jan-2024.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process